JP2016502995A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502995A5
JP2016502995A5 JP2015547071A JP2015547071A JP2016502995A5 JP 2016502995 A5 JP2016502995 A5 JP 2016502995A5 JP 2015547071 A JP2015547071 A JP 2015547071A JP 2015547071 A JP2015547071 A JP 2015547071A JP 2016502995 A5 JP2016502995 A5 JP 2016502995A5
Authority
JP
Japan
Prior art keywords
vaccine composition
vaccine
intranasal
composition according
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2015547071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502995A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/076905 external-priority patent/WO2014095866A1/en
Publication of JP2016502995A publication Critical patent/JP2016502995A/ja
Publication of JP2016502995A5 publication Critical patent/JP2016502995A5/ja
Ceased legal-status Critical Current

Links

JP2015547071A 2012-12-17 2013-12-17 鼻腔内予防接種投薬レジメン Ceased JP2016502995A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201270788 2012-12-17
DKPA201270788 2012-12-17
PCT/EP2013/076905 WO2014095866A1 (en) 2012-12-17 2013-12-17 Intranasal vaccination dosage regimen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018135426A Division JP2018172434A (ja) 2012-12-17 2018-07-19 鼻腔内予防接種投薬レジメン

Publications (2)

Publication Number Publication Date
JP2016502995A JP2016502995A (ja) 2016-02-01
JP2016502995A5 true JP2016502995A5 (https=) 2016-12-01

Family

ID=49880734

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015547071A Ceased JP2016502995A (ja) 2012-12-17 2013-12-17 鼻腔内予防接種投薬レジメン
JP2018135426A Pending JP2018172434A (ja) 2012-12-17 2018-07-19 鼻腔内予防接種投薬レジメン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018135426A Pending JP2018172434A (ja) 2012-12-17 2018-07-19 鼻腔内予防接種投薬レジメン

Country Status (7)

Country Link
US (1) US9700614B2 (https=)
EP (1) EP2931309A1 (https=)
JP (2) JP2016502995A (https=)
AU (1) AU2013361781B2 (https=)
HK (1) HK1215546A1 (https=)
PH (1) PH12015501459A1 (https=)
WO (1) WO2014095866A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
US12589149B2 (en) 2019-03-20 2026-03-31 Advagene Biopharma Co., Ltd. Method of modulating mucosal immunogenicity
US20260034203A1 (en) * 2022-08-02 2026-02-05 Yale University Compositions, kits, and methods of immunizing against viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60014076T2 (de) * 1999-04-19 2005-10-13 Glaxosmithkline Biologicals S.A. Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
CA2439111A1 (en) * 2001-04-05 2002-10-17 Chiron Corporation Mucosal boosting following parenteral priming
EP1885393A4 (en) * 2005-05-18 2011-03-02 Childrens Hosp & Res Ct Oak METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST CHLAMYDIA INFECTIONS
US20100158943A1 (en) * 2005-11-04 2010-06-24 Novartis Vaccines And Diagnostics Srl Administration routes for priming/boosting with influenza vaccines
US8535683B2 (en) 2006-03-22 2013-09-17 Abbott Biologicals B.V. Intranasal or inhalational administration of virosomes
EP1998814A4 (en) 2006-05-11 2010-06-16 Novavax Inc NEW VACCINES AGAINST INFLUENZA M2
GB0905570D0 (en) 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
US8658180B2 (en) 2008-08-15 2014-02-25 Mark A. Miller Vaccines against influenza virus
SI2396030T1 (sl) 2009-02-10 2015-12-31 Novartis Ag Sheme dajanja cepiva proti gripi za seve, povezane s pandemijo
CN103154021A (zh) 2010-08-16 2013-06-12 威斯特解剖及生物研究所 通用甲型流感疫苗
KR101857839B1 (ko) 2010-09-30 2018-05-14 유로씨네 백신즈 에이비 개선된 백신 조성물들

Similar Documents

Publication Publication Date Title
WO2013006842A3 (en) Self-replicating rna prime - protein boost vaccines
MX2020011781A (es) Formulacion arn para inmunoterapia.
EP4056198A3 (en) Outer membrane vesicles
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
WO2013177214A3 (en) Epitope focusing by variable effective antigen surface concentration
EP4494650A3 (en) Vaccine compositions having improved stability and immunogenicity
JP2009173664A5 (https=)
CR20160018A (es) Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)
MX392812B (es) Lipidos cationicos de trialquilo y metodos de uso de los mismos.
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
MX2023006203A (es) Vacunas novedosas contra el virus de zika.
PE20140845A1 (es) Formulaciones parenterales de vacunas contra los norovirus
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
AR101455A1 (es) Molécula portadora
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
FI3656395T3 (fi) Menetelmiä ja koostumuksia suojaavan immuniteetin aikaansaamiseksi filovirusinfektiota vastaan
WO2015140172A3 (en) A medicament for use in a method of inducing or extending a cellular cytotoxic immune response
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX349657B (es) Composiciones de vacuna de matriz de proteína que incluyen policationes.
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
RU2016116988A (ru) Вакцина против haemophilus parasuis серологического типа 4
WO2016191641A3 (en) Methods for enhancing antigen-specific immune responses using combination therapy comprising papillomavirus capsid antigens
HK1211980A1 (en) Multifunctional oral vaccine based on chromosome recombineering
JP2016502995A5 (https=)